Macclesfield, United Kingdom

Georges Pasquet

This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Georges Pasquet. Retrieved from https://idiyas.com/inventor/georges-pasquet-steb9l4x

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Georges Pasquet

Introduction

Georges Pasquet is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel therapeutic methods.

Latest Patents

Georges Pasquet holds a patent for "Methods of treatment using N-(3-fluorophenyl)-2-{3-[(7-{3-[ethyl(2-hydroxyethyl)amino]propoxy}-quinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide - Quinazoline derivatives of formula (I)." This patent involves compositions containing these derivatives, processes for their preparation, and their use in therapy.

Career Highlights

Georges Pasquet is associated with AstraZeneca Ab, a leading global biopharmaceutical company. His work focuses on innovative treatments that can improve patient outcomes.

Collaborations

He has collaborated with notable colleagues, including Nicola Murdoch Heron and Frederic H Jung, contributing to advancements in their shared field of expertise.

Conclusion

Georges Pasquet's work exemplifies the impact of innovation in the pharmaceutical industry, showcasing his dedication to developing effective therapeutic methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…